IV: INFECTIOUS DISEASE



ENDOCARDITIS (Arch Intern Med 2009;169(5):463)


History


•  RFs: IVDU, congenital or acquired valvular dz, prosthetic valves, structural heart dz, HD, indwelling venous catheters, cardiac surgery, bacteremia, chronic alcoholism, previous endocarditis


•  Difficult to Dx 2/2 nonspecific sx (lethargy, weak, anorexia, low-grade temp), or negative w/u


Findings


•  Fever (96%), new murmur (48%), CHF (32%), splenomegaly (11%), petechiae


•  Classic physical exam findings


•  Roth spots (2%): Exudative, edematous retinal lesions w/ central clearing


•  Osler nodes (3%): Violaceous tender nodules on toes & fingers


•  Janeway lesions (5%): Nontender, blanching, macular plaques on soles & palms


•  Splinter hemorrhages (8%): Nonblanching, linear, reddish-brown under nails


•  Septic emboli (mitral valve vegetations)


Diagnosis





Evaluation


•  EKG, CBC, Chem, coags; CXR, ↑ ESR/CRP (nonspecific), ≥2 blood cx


•  Typically Staph or Strep species; also gram-negative bacilli, Candida (prosthetic)


•  Echo for vegetations or valve ring abscesses; TEE more sens than TTE


Treatment


•  Hemodynamic stabilization if valve rupture, can present w/ acute pulmonary edema cultures


•  Immediate abx in suspected cases, preferably after blood cultures (see table)


Disposition


•  Admit w/ continuous telemetry & IV abx, ICU if hemodynamic compromise


Pearls


•  Infection of endothelium of heart (including but not limited to valves)


•  Consider cardiac surgery consultation for refractory CHF, fungal endocarditis, recurrent septic emboli, conduction disturbance, persistent sepsis, aneurysm rupture of sinus of Valsalva, kissing infection of anterior mitral leaflet w/ aortic valve endocarditis


•  Mortality w/ native valve dz: ∼25%; prosthetic valve higher


•  Worse prognosis if involves aortic valve, DM, S. aureus (30–40%)


•  Left-sided endocarditis (mitral 41%, aortic valve 31%) most common


•  IVDU: Tricuspid valve endocarditis; rheumatic valve dz: Mitral, then aortic valve




ABSCESS


Approach


•  ↓ activity of infiltrated local anesthetic agents b/c of the low pH of abscess area; consider regional nerve or field blocks + IV procedural sedation/analgesia


•  Gram stain & wound cx rarely necessary for skin or perirectal abscesses


•  Cx from intra-abdominal, spinal, or epidural abscesses usually sent from OR to guide therapy


•  Pharyngeal abscess cx can also help tailor antibiotic therapy


•  In diabetic, immunocompromised, w/ systemic sxs, septic, obtain labs & blood cultures, start IVF & abx & admit for IV abx


SOFT TISSUE


Cutaneous Abscess (Clin Infect Dis 2005;41(10):1373)


History


•  ↑ pain, tenderness & induration, usually w/o h/o fever or systemic tox


•  Disruption of skin from trauma or penetrating injury, often pt cannot recall injury


•  H/o IVDA/skin popping, prior MRSA abscesses


Findings


•  Exquisitely tender, soft, fluctuant mass surrounded by erythema


•  Most commonly Staph species, often polymicrobial


Evaluation


•  Blood work rarely needed unless appear systemically ill; US may help w/ localization


•  Culture from abscess only if tx w/ abx, severe infection, systemic illnesses, failed initial tx


Treatment


•  No abx indicated in healthy hosts unless cellulitis, fever, immunosuppression, failed I&D


•  I&D w/ regional nerve or field block ± procedural sedation


•  Create elliptical incision to prevent premature wound closure


•  Break up loculations in abscess cavity w/ hemostat


•  Consider irrigate & pack w/ 1/4-in gauze × 48 h (24 h if cosmetically important)


•  If surrounding cellulitis, nafcillin 2 g IV q4h, cefazolin 1 g IV q8h, or cephalexin PO


•  If for complicated abscess: Clindamycin, Bactrim, tetracycline, linezolid, vancomycin


Disposition


•  D/c w/ wound care instructions, 2-d f/u


•  Warm soaks TID × 2–3 d after removal of packing to allow continued wound drainage


Pearl


•  Can develop essentially anywhere: Furuncle, acne, skin breakdown, insect bites


•  Routine packing of abscesses after I&D is controversial


Paronychia


History


•  Pain & swelling lateral to nail edge; superficial infection of epithelium


•  No inciting injury but can be secondary to contaminated nail care instruments or trauma


Findings


•  Purulent collection lateral to nail bed w/ minimal surrounding erythema


•  Most commonly Staph or Strep species but can have mixed aerobic & anaerobic flora


Evaluation


•  No labs necessary


Treatment


•  No abx indicated in healthy hosts


•  Digital block w/ 1% lidocaine with or without epinephrine in each web space of affected digit


•  #11 blade scalpel to lift cuticle from nail on affected side & express purulent material


Disposition


•  D/c w/ wound care instructions, 2-d f/u


•  Warm soaks to finger TID × 2–3 d to allow complete drainage


Pearls


•  Often h/o manicure/pedicure, nail biting


•  If recurrent or chronic paronychia, consider Candida infection


•  May spread to pulp space of finger (felon) or deep spaces of hand, tendon if neglected


Pilonidal Cyst


History


•  Painful, tender abscess in alar cleft, often in obese or hirsute individuals


•  More prevalent in males; fever & systemic tox very rare


Findings


•  Painful, localized abscess in natal cleavage/midline sacrococcygeal region, 4–5 cm posterior to anal opening; surrounding erythema & fluctuance


•  Mixed flora: Staph or Strep species, anaerobic cocci, mixed aerobic & anaerobic flora


Evaluation


•  No labs necessary unless systemically ill


Treatment


•  Same as for cutaneous abscess, I&D


•  Surgical referral for excision of follicle & sinus tract after acute episode subsides


Disposition


•  D/c w/ wound care instructions, 2-d wound care f/u


Pearls


•  High recurrence rate (40–50%) unless follicle surgically removed


•  Thought to be caused by hair penetrating into subcutaneous tissues creating abscess


Bartholin Gland Cyst/Abscess


History


•  Severe localized pain in labia caused by obstructed Bartholin duct


•  Difficulty walking & sitting secondary to pain


•  Fever & signs of systemic tox are rare


Findings


•  Painful, tender, cystic mass on inferior lateral margin of vaginal introitus, often w/ purulent drainage from sinus tract


•  Typically anaerobes, MRSA, also Staph, Strep, & E. coli species, chlamydia, gonorrhea


Evaluation


•  Culture for chlamydia, gonorrhea


Treatment


•  I&D through mucosal surface, place Word catheter ×48 h


•  Sitz baths TID for the 1st 2–3 d to assist drainage


•  Gyn f/u for consideration of marsupialization to prevent recurrence


Disposition


•  D/c w/ wound care instructions, 2-d wound care f/u


Pearl


•  Recurrence rate still 5–15% after marsupialization; consider gyn malignancy


PERIRECTAL Abscesses (Int J Colorectal Dis 2012;27:831)


History


•  Pain & swelling in rectal area w/ defecation & often w/ sitting down or walking


•  High fever & signs of systemic tox are rare


•  Pts often have h/o Crohn dz, obesity, DM, or PID


Findings


•  Rectal exam essential to ensure abscess localized outside of anal sphincter & to identify upper extent of abscess


•  Typically E. coli species, Enterococcus, Bacteroides species, S. aureus, MRSA




Figure 4.1.


Evaluation


•  Lab studies unnecessary unless systemically ill


•  DM or immunocompromised should have Chem, CBC


•  CT/MRI if concern for intersphincteric or supralevator or postanal abscess or fistula


Treatment


•  ED I&D of superficial abscesses outside the anal verge w/ visible indurated area


•  Pain control; I&D extremely painful, procedural sedation often needed


•  If abscess is only identified on rectal exam & no induration visible, refer to surgery for I&D under general anesthesia


•  DM or immunocompromised pts should undergo I&D in OR to ensure full drainage


•  Pack w/ Vaseline gauze ×48 h, Sitz baths TID for 1st 2–3 d to assist drainage


•  No abx for healthy host w/ superficial abscess


•  Consider abx for immunocompromised, prosthetic device/valve, incomplete I&D


•  Levofloxacin 500 mg QD (ampicillin 1 g + gentamicin 80 mg q8h) + metronidazole 500 mg q8h, consider vancomycin


Disposition


•  D/c w/ wound care instructions, 2-d wound care f/u


•  Admit diabetic & immunocompromised for IV abx


Pearls


•  35–50% treated w/ I&D or spontaneous drainage will develop chronic anal fistula


•  Bilateral tenderness raises possibility of “horseshoe” abscess


INTRACRANIAL ABSCESS


History


•  Caused by contiguous spread (sinus, ear, dental), hematogenous seeding from distant infection, (endocarditis) or post-CNS surgery/penetrating trauma


•  HA (70–90%), fever (50%), meningismus, photophobia, sz (30%), vomiting (25–50%), AMS


•  Subacute time course (vs. meningitis or encephalitis)


Findings


•  Focal neuro deficits, low-grade fever, obtundation (mass effect), sz, AMS, nuchal rigidity (25%), papilledema (10–50%)


•  Wide variety of organisms depending on method of entry, 1/3 polymicrobial


Evaluation


•  Blood cultures, CBC (WBC nonspecific), Chem, coags


•  CT scan w/ & w/o IV contrast; MRI more sens for cerebritis, posterior fossa lesions


•  CSF findings nonspecific, avoid LP


Treatment


•  Emergency neurosurgical consult for drainage in OR; airway management, sz tx


•  Early IV abx w/ good CSF penetration, tailored to likely pathogen


•  Start broad-spectrum IV abx: Ceftriaxone 2 g + vancomycin 1 g + metronidazole 500 mg


•  Corticosteroids ONLY for tx of cerebral edema: Decadron 10 mg IV × 1 then 4 mg q6h


Disposition


•  Neurosurgical intervention for operative washout, 6–8 wk IV abx then 4–8 wk PO abx


Pearls


•  Mortality 24–27%, unless abscess ruptures into ventricular system (mortality 80%)


•  Morbidity from residual neuro deficits, new sz from scar tissue or neuropsych Δ (50%)


SOFT TISSUE INFECTIONS


Approach


•  Careful hx, associated sxs (V/D, cough, abd pain, AMS), progression


•  Check blood sugar if diabetic


•  Assess VS for significant abnormalities that may indicate serious infection (↓ BP, ↑ HR)


•  If immunosuppressed (HIV/AIDS, elderly, malnourished, chronic steroids) or neutropenic, more intensive eval & testing: CBC, Chem, UA & cx, CXR; consider blood cx & admission


•  If recent foreign travel: Consider travel-related infectious etiologies




DERMATOLOGIC


Cutaneous/Subcutaneous Cellulitis (Clin Infect Dis 2005;41(10):1373)


History


•  Often no h/o broken skin; ± local trauma, recent surgery, FB


•  May report fever, chills, malaise


Findings


•  Warm, blanching erythema & tenderness to palpation, mild to moderate swelling


•  ± distal skin disruption (eg, tinea pedis b/w toes w/ cellulitis of anterior shin)


Evaluation


•  If elevated BS, check Chem, UA; Rule out abscess clinically or with bedside ultrasound


•  Consider blood cultures, CBC w/ differential, chemistries, CRP, CPK in systemically ill pts


•  Bacterial cultures of inflamed area not indicated; only 10–50% positive


•  Most often caused by Strep or S. aureus (including MRSA); can be from metastatic seeding


Treatment


•  If LE cellulitis, recommend rest & elevation × 48 h, crutches if needed


•  PO abx: cephalexin 500 mg PO QID, dicloxacillin 500 mg PO QID, or Augmentin 500 mg PO TID


•  IV abx: Cefazolin, ceftriaxone, nafcillin


•  If PCN allergic: clindamycin 500 mg PO QID, or azithromycin 500 mg PO × 1, then 250 mg PO × 4 d, levofloxacin 500 mg QD × 5 d


•  If diabetic or immunocompromised, use broader coverage abx


•  Consider MRSA coverage: Vancomycin, gentamicin, tetracyclines, Bactrim, rifampin, Daptomycin, linezolid


•  Pain control w/ NSAID/APAP; if severe pain consider necrotizing infection


•  Wound débridement if infected, contaminated or devitalized wound


•  Surgery consult if aggressive/necrotizing infection/gas in soft tissue


Disposition


•  D/c w/ PO abx & 24–48 h f/u, strict return instructions


•  Admit if signs of systemic infection, DM, immunocompromise, failure of outpt tx


Pearls


•  Due to inflammation of dermal & subcutaneous tissue due to nonsuppurative bacteria, infection does not involve fascia or muscles


•  Consider Doppler vascular studies in single limb w/ diffuse swelling, posterior calf or medial thigh to rule out DVT


•  Mark border w/ permanent ink, write time & date


Erysipelas


History


•  Extremes of age, obesity, DM, CHF, postop, nephrotic syndrome at higher risk


•  Acute onset pain, erythema, induration


•  Initial fever & chills followed by painful rash 1–2 d later


•  May have systemic sxs: Myalgias, arthralgias, nausea, HA


Findings


•  Skin painful superficial, indurated, raised; erythema w/ sharply demarcated border


•  Irregular erythema w/ lymphangitis, may see desquamation, dimpling, vesicles, LAD


•  70–90% found on lower extremities, 5–20% on face, 5–6% on upper extremity


Evaluation


•  None indicated unless toxic appearing


Treatment


•  PCN G, amoxicillin, cefazolin 1 g IV q8h or azithromycin 500 mg PO


•  PCN allergic: Azithromycin, clindamycin, levofloxacin


Disposition


•  D/c w/ PO abx & analgesics, elevate affected area, 24–48 h f/u, strict return instructions


Pearls


•  Typically caused by group A β-hemolytic streptococcus; involves dermis, hypodermis, & lymphatics


•  More superficial than cellulitis


•  Recurrence rate 10–40%


Staphylococcal Scalded Skin Syndrome (SSSS) (Am J Clin Dermatol 2003;4(3):165)


History


•  Young children <5 yr, rare in adults, fairly rapid progression of prodromal sore throat, conjunctivitis, fever, malaise to painful red skin w/ sloughing


Findings


•  No mucous membrane involvement (vs. TEN)


•  Erythematous cellulitis followed by acute exfoliation: Bullae, vesicles → large sheets of skin loss resulting in scalded-appearing skin


•  General malaise, fever, irritability, tenderness to palpation, does not appear severely ill


Evaluation


•  None indicated unless systemically ill


•  Positive Nikolsky sign (epidermis separates when pressure applied)


Treatment


•  Similar to burns (IVF, topical wound care, burn consult)


•  Most recover w/o abx but still recommended: Nafcillin, vancomycin, clindamycin


Disposition


•  Admit for burn care, IVF; consider ICU


Pearls


•  Caused by exfoliative exotoxins of S. aureus, reports of MRSA


•  Separation of epidermal layers vs. more severe TEN (necrosis at level of basement membrane)


•  Prognosis: Children (4% mortality) often w/o significant scarring; adults (60% mortality)


Toxic Shock Syndrome (TSS)


History


•  Multiple sxs: Prodrome, pain at site of infection (out of proportion to findings), fever, chills, N/V, abd pain, watery diarrhea, myalgias, arthralgias, pharyngitis, HA, AMS


•  Recent surgery, infrequently changed packing (tampons, nasal packing)


Findings


•  Clinical Dx w/ findings from all organ systems:


•  Temp >38.9°C, ↓ BP (shock/hypovolemia), rash


•  “Sandpaper” diffuse, macular rash initially on trunk → spread to arms, legs, palms, soles → flaking full-thickness desquamation, 5–12 d after onset


•  Involvement of 3 organ systems (see table)


Evaluation


•  CBC w/ differential, Chem, UA, LFTs, coags, cultures (blood, urine, throat)


Treatment


•  Remove tampon or packing if still in place, drain abscesses if present; burn care


•  Aggressive resuscitation, pressors if needed, Foley catheter to monitor urine output


•  Abx, may not have impact (toxin-mediated process); tx any identified source


•  Nafcillin, vancomycin, clindamycin to suppress bacterial toxin synthesis; linezolid


•  High-dosed steroids reported to improve TSS in case reports


•  IVIG 400 mg/kg IV (has antibodies to TSS-1 & other exotoxins) for very ill pts w/ pulmonary edema or who require mechanical ventilation may reduce mortality


•  Surgical consult if debridable sources of infection


Disposition


•  ICU admission


Pearls


•  Rate ↓ w/ ↓ in use of superabsorbent tampons


•  Caused by inflammatory response to TSST-1 enterotoxin from Strep & Staph species


•  Strep: Usually after surgery or trauma; scarlet fever-like rash; 30–70% mortality, fulminant


•  Staph: More indolent, 5% mortality


•  Poor prognosis, mortality as high as 70%, 30–50% recurrence, most w/i 2 mo




Necrotizing Fasciitis


History


•  H/o mild trauma, often diabetic, PVD, EtOH abuse or nutritionally compromised


•  Sudden onset of pain & swelling which progresses to anesthesia


Findings


•  Fever, tenderness, erythema, toxic appearing


•  Pain out of proportion to exam &/or numbness, crepitus


•  Rapidly spreading, progressive erythema/infection of deep fascia w/ secondary necrosis of subcutaneous tissues, subcutaneous air (due gas-forming organisms)


•  Can progress to involvement of deeper layers, causing myositis or myonecrosis



Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 6, 2016 | Posted by in EMERGENCY MEDICINE | Comments Off on IV: INFECTIOUS DISEASE

Full access? Get Clinical Tree

Get Clinical Tree app for offline access